Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
Autor: | Helena M. VonVille, Michael D. Swartz, David S. Lopez, Krittiya Korphaisarn, Carrie R. Daniel, Scott Kopetz, Stacia M. DeSantis, Pragati Shailesh Advani, Jennifer S. Davis, Shailesh Advani, Jan Bressler, Dejana Braithwaite, Derek Brown, Amir Mehrvarz Sarshekeh |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Cancer Research
Alcohol Drinking Colorectal cancer India Biology Methylation lcsh:RC254-282 Cohort Studies Genetic Heterogeneity Geographic Risk Factors Genetics medicine Prevalence Humans Gene Silencing Promoter Regions Genetic neoplasms Colorectal Czech Republic CpG Island Methylator Phenotype CIMP Exploratory analysis DNA Methylation medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Confidence interval digestive system diseases Phenotype Oncology CpG site DNA methylation CpG Islands Epigenetics Colorectal Neoplasms Publication Bias Demography Research Article |
Zdroj: | BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019) BMC Cancer |
ISSN: | 1471-2407 |
Popis: | BackgroundCpG Island Methylator Phenotype (CIMP) is an epigenetic phenotype in CRC characterized by hypermethylation of CpG islands in promoter regions of tumor suppressor genes, leading to their transcriptional silencing and loss of function. While the prevalence of CRC differs across geographical regions, no studies have compared prevalence of CIMP-High phenotype across regions. The purpose of this project was to compare the prevalence of CIMP across geographical regions after adjusting for variations in methodologies to measure CIMP in a meta-analysis.MethodsWe searched PubMed, Medline, and Embase for articles focusing on CIMP published from 2000 to 2018. Two reviewers independently identified 111 articles to be included in final meta-analysis. We classified methods used to quantify CIMP into 4 categories: a) Classical (MINT marker) Panel group b) Weisenberg-Ogino (W-O) group c) Human Methylation Arrays group and d) Miscellaneous group. We compared the prevalence of CIMP across geographical regions after correcting for methodological variations using meta-regression techniques.ResultsThe pooled prevalence of CIMP-High across all studies was 22% (95% confidence interval:21–24%; I2 = 94.75%). Pooled prevalence of CIMP-H across Asia, Australia, Europe, North America and South America was 22, 21, 21, 27 and 25%, respectively. Meta-regression analysis identified no significant differences in the prevalence of CIMP-H across geographical regions after correction for methodological variations. In exploratory analysis, we observed variations in CIMP-H prevalence across countries.ConclusionAlthough no differences were found for CIMP-H prevalence across countries, further studies are needed to compare the influence of demographic, lifestyle and environmental factors in relation to the prevalence of CIMP across geographical regions. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |